{"schema_version":"secwatch.filing_event.v1","accession":"0000885725-24-000060","form_type":"8-K","ticker":"BSX","cik":"0000885725","company_name":"BOSTON SCIENTIFIC CORP","filed_at":"2024-07-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.171098+00:00","generated_at":"2026-05-31T17:42:52.965922+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Boston Scientific Q2 net sales $4.12B (+14.5% reported), adj EPS $0.62, above guidance; acquires Silk Road Medical","bullets":["Q2 net sales $4.120B, up 14.5% reported (16.1% operational, 14.7% organic); GAAP EPS $0.22, adjusted EPS $0.62 vs guidance $0.57-$0.59.","Cardiovascular segment sales grew 17.8% reported; MedSurg grew 9.0%; U.S. sales up 16.9%.","Received China NMPA approval for FARAPULSE PFA System; launched AGENT Drug-Coated Balloon in U.S. and received China NMPA approval.","Announced agreement to acquire Silk Road Medical (SILK) for stroke prevention; subject to customary closing conditions.","FY2024 guidance: reported sales growth 13.5-14.5%, adj EPS $2.38-$2.42; Q3 guidance: adj EPS $0.57-$0.59."],"urls":{"canonical":"https://secwatch.observer/filing/0000885725-24-000060","json":"https://secwatch.observer/filing/0000885725-24-000060.json","markdown":"https://secwatch.observer/filing/0000885725-24-000060.md","text":"https://secwatch.observer/filing/0000885725-24-000060.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/885725/000088572524000060/0000885725-24-000060-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/885725/000088572524000060/bsx-20240724.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T17:42:52.965922+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}